Boston Scientific
632 hedge funds and large institutions have $31B invested in Boston Scientific in 2017 Q4 according to their latest regulatory filings, with 129 funds opening new positions, 216 increasing their positions, 194 reducing their positions, and 41 closing their positions.
215% more first-time investments, than exits
New positions opened: 129 | Existing positions closed: 41
30% more funds holding in top 10
Funds holding in top 10: 10 → 13 (+3)
16% more funds holding
Funds holding: 547 → 632 (+85)
11% more repeat investments, than reductions
Existing positions increased: 216 | Existing positions reduced: 194
0.54% less ownership
Funds ownership: 91.69% → 91.15% (-0.54%)
12% less call options, than puts
Call options by funds: $53.5M | Put options by funds: $60.8M
15% less capital invested
Capital invested by funds: $36.7B → $31B (-$5.64B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$266M |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$219M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$155M |
| 4 |
D.E. Shaw & Co
New York
|
+$133M |
| 5 |
Goldman Sachs
New York
|
+$116M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$586M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$327M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$214M |
| 4 |
Jennison Associates
New York
|
-$178M |
| 5 |
JP Morgan Chase
New York
|
-$147M |
BSX Hedge Fund Activity: Q4 2017 in Review
632 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2017, worth a combined $31B — down 15% from $36.7B a quarter earlier.
Buyers outnumbered sellers: 129 funds opened new BSX positions and 41 closed out — a net gain of 88 holders — while 216 added to existing stakes and 194 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $266M. The largest seller was Fidelity Investments, cutting an estimated $586M.
- 632 institutional investors held Boston Scientific (BSX) as of Q4 2017, up from 547 in Q3 2017.
- Funds reported $31B of Boston Scientific stock for Q4 2017, down 15% quarter-over-quarter.
- 129 funds opened new Boston Scientific positions in Q4 2017 and 41 closed out, a net change of +88 holders.
- The largest Boston Scientific buyer in Q4 2017 was Wellington Management Group, an estimated $266M added.
- The largest Boston Scientific seller in Q4 2017 was Fidelity Investments, an estimated $586M sold.
Based on aggregated 13F filings for Q4 2017.